ReviewCancers2025
CDK4/6 as a Therapeutic Target in HR+/HER2- Breast Cancer Cells-Current Treatment Status.
Kamila Krupa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewCancers2025
Kamila Krupa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.